Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000119508 | SCV000852404 | uncertain significance | not provided | 2016-06-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001854162 | SCV002145858 | pathogenic | RYR1-related disorder | 2021-04-02 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RYR1 protein function. This variant has been observed in individual(s) with autosomal dominant central core disease (PMID: 11709545, Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 65962). This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with proline at codon 4793 of the RYR1 protein (p.Leu4793Pro). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and proline. |
Gene |
RCV000056209 | SCV000087298 | pathologic | Central core myopathy | 2010-05-11 | no assertion criteria provided | curation | Converted during submission to Pathogenic. |
Leiden Muscular Dystrophy |
RCV000119508 | SCV000154415 | not provided | not provided | no assertion provided | not provided |